Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes

Micheal S. Ward, Nicole B. Flemming, Linda A. Gallo, Amelia K. Fotheringham, Domenica A. McCarthy, Aowen Zhuang, Peter H. Tang, Danielle J. Borg1, Hannah Shaw, Benjamin Harvie, David R. Briskey, Llion A. Roberts, Manuel R. Plan, Michael P. Murphy, Mark P. Hodson, & Josephine M. Forbes, “Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes,” Scientific Reports 2017, 7: 15190, DOI:10.1038/s41598-017-15589-x.